https://www.selleckchem.com/products/gdc-0077.html
BACKGROUND Not all patients with cough variant asthma (CVA) show responsiveness to bronchodilators (R in clinic. Whether there are specific clinical and pathophysiological features can indicate RB in patients with CVA needs further investigation. Thus, we aimed to investigate the RB in patients with CVA and associated factors. METHODS Forty-two CVA patients were randomized in a 21 ratio to receive oral bambuterol hydrochloride (10 mg, once daily, for 3 days) or matched placebo, 36 patients (24 with bronchodilator and 12 with placebo)
Like
Comment
Share
